Global CRISPR And CRISPR-Associated (Cas) Genes Market Growth 2020-2025
According to this study, over the next five years the CRISPR And CRISPR-Associated (Cas) Genes market will register a 41.5%% CAGR in terms of revenue, the global market size will reach $ 2799 million by 2025, from $ 698.3 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in CRISPR And CRISPR-Associated (Cas) Genes business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of CRISPR And CRISPR-Associated (Cas) Genes market by product type, application, key manufacturers and key regions and countries.
This study specially analyses the impact of Covid-19 outbreak on the CRISPR And CRISPR-Associated (Cas) Genes, covering the supply chain analysis, impact assessment to the CRISPR And CRISPR-Associated (Cas) Genes market size growth rate in several scenarios, and the measures to be undertaken by CRISPR And CRISPR-Associated (Cas) Genes companies in response to the COVID-19 epidemic.
Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.
Genome Editing
Genetic engineering
gRNA Database/Gene Librar
CRISPR Plasmid
Human Stem Cells
Genetically Modified Organisms/Crops
Cell Line Engineering
Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.
Biotechnology Companies
Pharmaceutical Companies
Academic Institutes
Research and Development Institutes
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Caribou Biosciences
Intellia Therapeutics
Addgene
Merck KGaA
Mirus Bio LLC
CRISPR THERAPEUTICS
Thermo Fisher Scientific
Editas Medicine
Horizon Discovery Group
Takara Bio USA
GE Healthcare Dharmacon
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global CRISPR And CRISPR-Associated (Cas) Genes consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of CRISPR And CRISPR-Associated (Cas) Genes market by identifying its various subsegments.
Focuses on the key global CRISPR And CRISPR-Associated (Cas) Genes manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the CRISPR And CRISPR-Associated (Cas) Genes with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of CRISPR And CRISPR-Associated (Cas) Genes submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global CRISPR And CRISPR-Associated (Cas) Genes Consumption 2015-2025
2.1.2 CRISPR And CRISPR-Associated (Cas) Genes Consumption CAGR by Region
2.2 CRISPR And CRISPR-Associated (Cas) Genes Segment by Type
2.2.1 Genome Editing
2.2.2 Genetic engineering
2.2.3 gRNA Database/Gene Librar
2.2.4 CRISPR Plasmid
2.2.5 Human Stem Cells
2.2.6 Genetically Modified Organisms/Crops
2.2.7 Cell Line Engineering
2.3 CRISPR And CRISPR-Associated (Cas) Genes Consumption by Type
2.3.1 Global CRISPR And CRISPR-Associated (Cas) Genes Consumption Market Share by Type (2015-2020)
2.3.2 Global CRISPR And CRISPR-Associated (Cas) Genes Revenue and Market Share by Type (2015-2020)
2.3.3 Global CRISPR And CRISPR-Associated (Cas) Genes Sale Price by Type (2015-2020)
2.4 CRISPR And CRISPR-Associated (Cas) Genes Segment by Application
2.4.1 Biotechnology Companies
2.4.2 Pharmaceutical Companies
2.4.3 Academic Institutes
2.4.4 Research and Development Institutes
2.5 CRISPR And CRISPR-Associated (Cas) Genes Consumption by Application
2.5.1 Global CRISPR And CRISPR-Associated (Cas) Genes Consumption Market Share by Type (2015-2020)
2.5.2 Global CRISPR And CRISPR-Associated (Cas) Genes Value and Market Share by Type (2015-2020)
2.5.3 Global CRISPR And CRISPR-Associated (Cas) Genes Sale Price by Type (2015-2020)
3 Global CRISPR And CRISPR-Associated (Cas) Genes by Company
3.1 Global CRISPR And CRISPR-Associated (Cas) Genes Sales Market Share by Company
3.1.1 Global CRISPR And CRISPR-Associated (Cas) Genes Sales by Company (2018-2020)
3.1.2 Global CRISPR And CRISPR-Associated (Cas) Genes Sales Market Share by Company (2018-2020)
3.2 Global CRISPR And CRISPR-Associated (Cas) Genes Revenue Market Share by Company
3.2.1 Global CRISPR And CRISPR-Associated (Cas) Genes Revenue by Company (2018-2020)
3.2.2 Global CRISPR And CRISPR-Associated (Cas) Genes Revenue Market Share by Company (2018-2020)
3.3 Global CRISPR And CRISPR-Associated (Cas) Genes Sale Price by Company
3.4 Global CRISPR And CRISPR-Associated (Cas) Genes Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global CRISPR And CRISPR-Associated (Cas) Genes Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players CRISPR And CRISPR-Associated (Cas) Genes Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 CRISPR And CRISPR-Associated (Cas) Genes by Regions
4.1 CRISPR And CRISPR-Associated (Cas) Genes by Regions
4.2 Americas CRISPR And CRISPR-Associated (Cas) Genes Consumption Growth
4.3 APAC CRISPR And CRISPR-Associated (Cas) Genes Consumption Growth
4.4 Europe CRISPR And CRISPR-Associated (Cas) Genes Consumption Growth
4.5 Middle East & Africa CRISPR And CRISPR-Associated (Cas) Genes Consumption Growth
5 Americas
5.1 Americas CRISPR And CRISPR-Associated (Cas) Genes Consumption by Countries
5.1.1 Americas CRISPR And CRISPR-Associated (Cas) Genes Consumption by Countries (2015-2020)
5.1.2 Americas CRISPR And CRISPR-Associated (Cas) Genes Value by Countries (2015-2020)
5.2 Americas CRISPR And CRISPR-Associated (Cas) Genes Consumption by Type
5.3 Americas CRISPR And CRISPR-Associated (Cas) Genes Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC CRISPR And CRISPR-Associated (Cas) Genes Consumption by Regions
6.1.1 APAC CRISPR And CRISPR-Associated (Cas) Genes Consumption by Regions (2015-2020)
6.1.2 APAC CRISPR And CRISPR-Associated (Cas) Genes Value by Regions (2015-2020)
6.2 APAC CRISPR And CRISPR-Associated (Cas) Genes Consumption by Type
6.3 APAC CRISPR And CRISPR-Associated (Cas) Genes Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions
7 Europe
7.1 Europe CRISPR And CRISPR-Associated (Cas) Genes by Countries
7.1.1 Europe CRISPR And CRISPR-Associated (Cas) Genes Consumption by Countries (2015-2020)
7.1.2 Europe CRISPR And CRISPR-Associated (Cas) Genes Value by Countries (2015-2020)
7.2 Europe CRISPR And CRISPR-Associated (Cas) Genes Consumption by Type
7.3 Europe CRISPR And CRISPR-Associated (Cas) Genes Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa CRISPR And CRISPR-Associated (Cas) Genes by Countries
8.1.1 Middle East & Africa CRISPR And CRISPR-Associated (Cas) Genes Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa CRISPR And CRISPR-Associated (Cas) Genes Value by Countries (2015-2020)
8.2 Middle East & Africa CRISPR And CRISPR-Associated (Cas) Genes Consumption by Type
8.3 Middle East & Africa CRISPR And CRISPR-Associated (Cas) Genes Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 CRISPR And CRISPR-Associated (Cas) Genes Distributors
10.3 CRISPR And CRISPR-Associated (Cas) Genes Customer
11 Global CRISPR And CRISPR-Associated (Cas) Genes Market Forecast
11.1 Global CRISPR And CRISPR-Associated (Cas) Genes Consumption Forecast (2021-2025)
11.2 Global CRISPR And CRISPR-Associated (Cas) Genes Forecast by Regions
11.2.1 Global CRISPR And CRISPR-Associated (Cas) Genes Forecast by Regions (2021-2025)
11.2.2 Global CRISPR And CRISPR-Associated (Cas) Genes Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global CRISPR And CRISPR-Associated (Cas) Genes Forecast by Type
11.8 Global CRISPR And CRISPR-Associated (Cas) Genes Forecast by Application
12 Key Players Analysis
12.1 Caribou Biosciences
12.1.1 Company Information
12.1.2 CRISPR And CRISPR-Associated (Cas) Genes Product Offered
12.1.3 Caribou Biosciences CRISPR And CRISPR-Associated (Cas) Genes Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 Caribou Biosciences Latest Developments
12.2 Intellia Therapeutics
12.2.1 Company Information
12.2.2 CRISPR And CRISPR-Associated (Cas) Genes Product Offered
12.2.3 Intellia Therapeutics CRISPR And CRISPR-Associated (Cas) Genes Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 Intellia Therapeutics Latest Developments
12.3 Addgene
12.3.1 Company Information
12.3.2 CRISPR And CRISPR-Associated (Cas) Genes Product Offered
12.3.3 Addgene CRISPR And CRISPR-Associated (Cas) Genes Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 Addgene Latest Developments
12.4 Merck KGaA
12.4.1 Company Information
12.4.2 CRISPR And CRISPR-Associated (Cas) Genes Product Offered
12.4.3 Merck KGaA CRISPR And CRISPR-Associated (Cas) Genes Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 Merck KGaA Latest Developments
12.5 Mirus Bio LLC
12.5.1 Company Information
12.5.2 CRISPR And CRISPR-Associated (Cas) Genes Product Offered
12.5.3 Mirus Bio LLC CRISPR And CRISPR-Associated (Cas) Genes Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 Mirus Bio LLC Latest Developments
12.6 CRISPR THERAPEUTICS
12.6.1 Company Information
12.6.2 CRISPR And CRISPR-Associated (Cas) Genes Product Offered
12.6.3 CRISPR THERAPEUTICS CRISPR And CRISPR-Associated (Cas) Genes Sales, Revenue, Price and Gross Margin (2018-2020)
12.6.4 Main Business Overview
12.6.5 CRISPR THERAPEUTICS Latest Developments
12.7 Thermo Fisher Scientific
12.7.1 Company Information
12.7.2 CRISPR And CRISPR-Associated (Cas) Genes Product Offered
12.7.3 Thermo Fisher Scientific CRISPR And CRISPR-Associated (Cas) Genes Sales, Revenue, Price and Gross Margin (2018-2020)
12.7.4 Main Business Overview
12.7.5 Thermo Fisher Scientific Latest Developments
12.8 Editas Medicine
12.8.1 Company Information
12.8.2 CRISPR And CRISPR-Associated (Cas) Genes Product Offered
12.8.3 Editas Medicine CRISPR And CRISPR-Associated (Cas) Genes Sales, Revenue, Price and Gross Margin (2018-2020)
12.8.4 Main Business Overview
12.8.5 Editas Medicine Latest Developments
12.9 Horizon Discovery Group
12.9.1 Company Information
12.9.2 CRISPR And CRISPR-Associated (Cas) Genes Product Offered
12.9.3 Horizon Discovery Group CRISPR And CRISPR-Associated (Cas) Genes Sales, Revenue, Price and Gross Margin (2018-2020)
12.9.4 Main Business Overview
12.9.5 Horizon Discovery Group Latest Developments
12.10 Takara Bio USA
12.10.1 Company Information
12.10.2 CRISPR And CRISPR-Associated (Cas) Genes Product Offered
12.10.3 Takara Bio USA CRISPR And CRISPR-Associated (Cas) Genes Sales, Revenue, Price and Gross Margin (2018-2020)
12.10.4 Main Business Overview
12.10.5 Takara Bio USA Latest Developments
12.11 GE Healthcare Dharmacon
12.11.1 Company Information
12.11.2 CRISPR And CRISPR-Associated (Cas) Genes Product Offered
12.11.3 GE Healthcare Dharmacon CRISPR And CRISPR-Associated (Cas) Genes Sales, Revenue, Price and Gross Margin (2018-2020)
12.11.4 Main Business Overview
12.11.5 GE Healthcare Dharmacon Latest Developments
13 Research Findings and Conclusion
Tables and Figures
List of Tables
Table 1. Research Methodology
Table 2. Data Source
Table 3. CRISPR And CRISPR-Associated (Cas) Genes Consumption CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Players of Genome Editing
Table 5. Major Players of Genetic engineering
Table 6. Major Players of gRNA Database/Gene Librar
Table 7. Major Players of CRISPR Plasmid
Table 8. Major Players of Human Stem Cells
Table 9. Major Players of Genetically Modified Organisms/Crops
Table 10. Major Players of Cell Line Engineering
Table 11. Global Consumption Sales by Type (2015-2020)
Table 12. Global CRISPR And CRISPR-Associated (Cas) Genes Consumption Market Share by Type (2015-2020)
Table 13. Global CRISPR And CRISPR-Associated (Cas) Genes Revenue by Type (2015-2020) ($ million)
Table 14. Global CRISPR And CRISPR-Associated (Cas) Genes Value Market Share by Type (2015-2020) ($ Millions)
Table 15. Global CRISPR And CRISPR-Associated (Cas) Genes Sale Price by Type (2015-2020)
Table 16. Global Consumption Sales by Application (2015-2020)
Table 17. Global CRISPR And CRISPR-Associated (Cas) Genes Consumption Market Share by Application (2015-2020)
Table 18. Global CRISPR And CRISPR-Associated (Cas) Genes Value by Application (2015-2020)
Table 19. Global CRISPR And CRISPR-Associated (Cas) Genes Value Market Share by Application (2015-2020)
Table 20. Global CRISPR And CRISPR-Associated (Cas) Genes Sale Price by Application (2015-2020)
Table 21. Global CRISPR And CRISPR-Associated (Cas) Genes Sales by Company (2017-2019) (K Units)
Table 22. Global CRISPR And CRISPR-Associated (Cas) Genes Sales Market Share by Company (2017-2019)
Table 23. Global CRISPR And CRISPR-Associated (Cas) Genes Revenue by Company (2017-2019) ($ Millions)
Table 24. Global CRISPR And CRISPR-Associated (Cas) Genes Revenue Market Share by Company (2017-2019)
Table 25. Global CRISPR And CRISPR-Associated (Cas) Genes Sale Price by Company (2017-2019)
Table 26. Global CRISPR And CRISPR-Associated (Cas) Genes Manufacturing Base Distribution and Sales Area by Manufacturers
Table 27. Players CRISPR And CRISPR-Associated (Cas) Genes Products Offered
Table 28. CRISPR And CRISPR-Associated (Cas) Genes Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
Table 29. Global CRISPR And CRISPR-Associated (Cas) Genes Consumption by Regions 2015-2020 (K Units)
Table 30. Global CRISPR And CRISPR-Associated (Cas) Genes Consumption Market Share by Regions 2015-2020
Table 31. Global CRISPR And CRISPR-Associated (Cas) Genes Value by Regions 2015-2020 ($ Millions)
Table 32. Global CRISPR And CRISPR-Associated (Cas) Genes Value Market Share by Regions 2015-2020
Table 33. Americas CRISPR And CRISPR-Associated (Cas) Genes Consumption by Countries (2015-2020) (K Units)
Table 34. Americas CRISPR And CRISPR-Associated (Cas) Genes Consumption Market Share by Countries (2015-2020)
Table 35. Americas CRISPR And CRISPR-Associated (Cas) Genes Value by Countries (2015-2020) ($ Millions)
Table 36. Americas CRISPR And CRISPR-Associated (Cas) Genes Value Market Share by Countries (2015-2020)
Table 37. Americas CRISPR And CRISPR-Associated (Cas) Genes Consumption by Type (2015-2020) (K Units)
Table 38. Americas CRISPR And CRISPR-Associated (Cas) Genes Consumption Market Share by Type (2015-2020)
Table 39. Americas CRISPR And CRISPR-Associated (Cas) Genes Consumption by Application (2015-2020) (K Units)
Table 40. Americas CRISPR And CRISPR-Associated (Cas) Genes Consumption Market Share by Application (2015-2020)
Table 41. APAC CRISPR And CRISPR-Associated (Cas) Genes Consumption by Countries (2015-2020) (K Units)
Table 42. APAC CRISPR And CRISPR-Associated (Cas) Genes Consumption Market Share by Countries (2015-2020)
Table 43. APAC CRISPR And CRISPR-Associated (Cas) Genes Value by Regions (2015-2020) ($ Millions)
Table 44. APAC CRISPR And CRISPR-Associated (Cas) Genes Value Market Share by Regions (2015-2020)
Table 45. APAC CRISPR And CRISPR-Associated (Cas) Genes Consumption by Type (2015-2020) (K Units)
Table 46. APAC CRISPR And CRISPR-Associated (Cas) Genes Consumption Market Share by Type (2015-2020)
Table 47. APAC CRISPR And CRISPR-Associated (Cas) Genes Consumption by Application (2015-2020) (K Units)
Table 48. APAC CRISPR And CRISPR-Associated (Cas) Genes Consumption Market Share by Application (2015-2020)
Table 49. Europe CRISPR And CRISPR-Associated (Cas) Genes Consumption by Countries (2015-2020) (K Units)
Table 50. Europe CRISPR And CRISPR-Associated (Cas) Genes Consumption Market Share by Countries (2015-2020)
Table 51. Europe CRISPR And CRISPR-Associated (Cas) Genes Value by Countries (2015-2020) ($ Millions)
Table 52. Europe CRISPR And CRISPR-Associated (Cas) Genes Value Market Share by Countries (2015-2020)
Table 53. Europe CRISPR And CRISPR-Associated (Cas) Genes Consumption by Type (2015-2020) (K Units)
Table 54. Europe CRISPR And CRISPR-Associated (Cas) Genes Consumption Market Share by Type (2015-2020)
Table 55. Europe CRISPR And CRISPR-Associated (Cas) Genes Consumption by Application (2015-2020) (K Units)
Table 56. Europe CRISPR And CRISPR-Associated (Cas) Genes Consumption Market Share by Application (2015-2020)
Table 57. Middle East & Africa CRISPR And CRISPR-Associated (Cas) Genes Consumption by Countries (2015-2020) (K Units)
Table 58. Middle East & Africa CRISPR And CRISPR-Associated (Cas) Genes Consumption Market Share by Countries (2015-2020)
Table 59. Middle East & Africa CRISPR And CRISPR-Associated (Cas) Genes Value by Countries (2015-2020) ($ Millions)
Table 60. Middle East & Africa CRISPR And CRISPR-Associated (Cas) Genes Value Market Share by Countries (2015-2020)
Table 61. Middle East & Africa CRISPR And CRISPR-Associated (Cas) Genes Consumption by Type (2015-2020) (K Units)
Table 62. Middle East & Africa CRISPR And CRISPR-Associated (Cas) Genes Consumption Market Share by Type (2015-2020)
Table 63. Middle East & Africa CRISPR And CRISPR-Associated (Cas) Genes Consumption by Application (2015-2020) (K Units)
Table 64. Middle East & Africa CRISPR And CRISPR-Associated (Cas) Genes Consumption Market Share by Application (2015-2020)
Table 65. CRISPR And CRISPR-Associated (Cas) Genes Distributors List
Table 66. CRISPR And CRISPR-Associated (Cas) Genes Customer List
Table 67. Global CRISPR And CRISPR-Associated (Cas) Genes Consumption Forecast by Countries (2021-2025) (K Units)
Table 68. Global CRISPR And CRISPR-Associated (Cas) Genes Consumption Market Forecast by Regions
Table 69. Global CRISPR And CRISPR-Associated (Cas) Genes Value Forecast by Countries (2021-2025) ($ Millions)
Table 70. Global CRISPR And CRISPR-Associated (Cas) Genes Value Market Share Forecast by Regions
Table 71. Global CRISPR And CRISPR-Associated (Cas) Genes Consumption Forecast by Type (2021-2025) (K Units)
Table 72. Global CRISPR And CRISPR-Associated (Cas) Genes Consumption Market Share Forecast by Type (2021-2025)
Table 73. Global CRISPR And CRISPR-Associated (Cas) Genes Value Forecast by Type (2021-2025) ($ Millions)
Table 74. Global CRISPR And CRISPR-Associated (Cas) Genes Value Market Share Forecast by Type (2021-2025)
Table 75. Global CRISPR And CRISPR-Associated (Cas) Genes Consumption Forecast by Application (2021-2025) (K Units)
Table 76. Global CRISPR And CRISPR-Associated (Cas) Genes Consumption Market Share Forecast by Application (2021-2025)
Table 77. Global CRISPR And CRISPR-Associated (Cas) Genes Value Forecast by Application (2021-2025) ($ Millions)
Table 78. Global CRISPR And CRISPR-Associated (Cas) Genes Value Market Share Forecast by Application (2021-2025)
Table 79. Caribou Biosciences Product Offered
Table 80. Caribou Biosciences CRISPR And CRISPR-Associated (Cas) Genes Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 81. Caribou Biosciences Main Business
Table 82. Caribou Biosciences Latest Developments
Table 83. Caribou Biosciences Basic Information, Company Total Revenue (in $ million), CRISPR And CRISPR-Associated (Cas) Genes Manufacturing Base, Sales Area and Its Competitors
Table 84. Intellia Therapeutics Product Offered
Table 85. Intellia Therapeutics CRISPR And CRISPR-Associated (Cas) Genes Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 86. Intellia Therapeutics Main Business
Table 87. Intellia Therapeutics Latest Developments
Table 88. Intellia Therapeutics Basic Information, Company Total Revenue (in $ million), CRISPR And CRISPR-Associated (Cas) Genes Manufacturing Base, Sales Area and Its Competitors
Table 89. Addgene Product Offered
Table 90. Addgene CRISPR And CRISPR-Associated (Cas) Genes Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 91. Addgene Main Business
Table 92. Addgene Latest Developments
Table 93. Addgene Basic Information, Company Total Revenue (in $ million), CRISPR And CRISPR-Associated (Cas) Genes Manufacturing Base, Sales Area and Its Competitors
Table 94. Merck KGaA Product Offered
Table 95. Merck KGaA CRISPR And CRISPR-Associated (Cas) Genes Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 96. Merck KGaA Main Business
Table 97. Merck KGaA Latest Developments
Table 98. Merck KGaA Basic Information, Company Total Revenue (in $ million), CRISPR And CRISPR-Associated (Cas) Genes Manufacturing Base, Sales Area and Its Competitors
Table 99. Mirus Bio LLC Product Offered
Table 100. Mirus Bio LLC CRISPR And CRISPR-Associated (Cas) Genes Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 101. Mirus Bio LLC Main Business
Table 102. Mirus Bio LLC Latest Developments
Table 103. Mirus Bio LLC Basic Information, Company Total Revenue (in $ million), CRISPR And CRISPR-Associated (Cas) Genes Manufacturing Base, Sales Area and Its Competitors
Table 104. CRISPR THERAPEUTICS Product Offered
Table 105. CRISPR THERAPEUTICS CRISPR And CRISPR-Associated (Cas) Genes Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 106. CRISPR THERAPEUTICS Main Business
Table 107. CRISPR THERAPEUTICS Latest Developments
Table 108. CRISPR THERAPEUTICS Basic Information, Company Total Revenue (in $ million), CRISPR And CRISPR-Associated (Cas) Genes Manufacturing Base, Sales Area and Its Competitors
Table 109. Thermo Fisher Scientific Product Offered
Table 110. Thermo Fisher Scientific Basic Information, Company Total Revenue (in $ million), CRISPR And CRISPR-Associated (Cas) Genes Manufacturing Base, Sales Area and Its Competitors
Table 111. Thermo Fisher Scientific Main Business
Table 112. Thermo Fisher Scientific Latest Developments
Table 113. Thermo Fisher Scientific CRISPR And CRISPR-Associated (Cas) Genes Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 114. Editas Medicine Product Offered
Table 115. Editas Medicine CRISPR And CRISPR-Associated (Cas) Genes Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 116. Editas Medicine Main Business
Table 117. Editas Medicine Latest Developments
Table 118. Editas Medicine Basic Information, Company Total Revenue (in $ million), CRISPR And CRISPR-Associated (Cas) Genes Manufacturing Base, Sales Area and Its Competitors
Table 119. Horizon Discovery Group Product Offered
Table 120. Horizon Discovery Group CRISPR And CRISPR-Associated (Cas) Genes Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 121. Horizon Discovery Group Main Business
Table 122. Horizon Discovery Group Latest Developments
Table 123. Horizon Discovery Group Basic Information, Company Total Revenue (in $ million), CRISPR And CRISPR-Associated (Cas) Genes Manufacturing Base, Sales Area and Its Competitors
Table 124. Takara Bio USA Product Offered
Table 125. Takara Bio USA CRISPR And CRISPR-Associated (Cas) Genes Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 126. Takara Bio USA Main Business
Table 127. Takara Bio USA Latest Developments
Table 128. Takara Bio USA Basic Information, Company Total Revenue (in $ million), CRISPR And CRISPR-Associated (Cas) Genes Manufacturing Base, Sales Area and Its Competitors
Table 129. GE Healthcare Dharmacon Product Offered
Table 130. GE Healthcare Dharmacon CRISPR And CRISPR-Associated (Cas) Genes Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 131. GE Healthcare Dharmacon Main Business
Table 132. GE Healthcare Dharmacon Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 133. GE Healthcare Dharmacon Latest Developments
List of Figures
Figure 1. Picture of CRISPR And CRISPR-Associated (Cas) Genes
Figure 2. CRISPR And CRISPR-Associated (Cas) Genes Report Years Considered
Figure 3. Market Research Methodology
Figure 4. Global CRISPR And CRISPR-Associated (Cas) Genes Consumption Growth Rate 2015-2025 (K Units)
Figure 5. Global CRISPR And CRISPR-Associated (Cas) Genes Value Growth Rate 2015-2025 ($ Millions)
Figure 6. Product Picture of Genome Editing
Figure 7. Product Picture of Genetic engineering
Figure 8. Product Picture of gRNA Database/Gene Librar
Figure 9. Product Picture of CRISPR Plasmid
Figure 10. Product Picture of Human Stem Cells
Figure 11. Product Picture of Genetically Modified Organisms/Crops
Figure 12. Product Picture of Cell Line Engineering
Figure 13. Global CRISPR And CRISPR-Associated (Cas) Genes Consumption Market Share by Type (2015-2020)
Figure 14. Global CRISPR And CRISPR-Associated (Cas) Genes Value Market Share by Type (2015-2020)
Figure 15. CRISPR And CRISPR-Associated (Cas) Genes Consumed in Biotechnology Companies
Figure 16. Global CRISPR And CRISPR-Associated (Cas) Genes Market: Biotechnology Companies (2015-2020) (K Units)
Figure 17. Global CRISPR And CRISPR-Associated (Cas) Genes Market: Biotechnology Companies (2015-2020) ($ Millions)
Figure 18. CRISPR And CRISPR-Associated (Cas) Genes Consumed in Pharmaceutical Companies
Figure 19. Global CRISPR And CRISPR-Associated (Cas) Genes Market: Pharmaceutical Companies (2015-2020) (K Units)
Figure 20. Global CRISPR And CRISPR-Associated (Cas) Genes Market: Pharmaceutical Companies (2015-2020) ($ Millions)
Figure 21. CRISPR And CRISPR-Associated (Cas) Genes Consumed in Academic Institutes
Figure 22. Global CRISPR And CRISPR-Associated (Cas) Genes Market: Academic Institutes (2015-2020) (K Units)
Figure 23. Global CRISPR And CRISPR-Associated (Cas) Genes Market: Academic Institutes (2015-2020) ($ Millions)
Figure 24. CRISPR And CRISPR-Associated (Cas) Genes Consumed in Research and Development Institutes
Figure 25. Global CRISPR And CRISPR-Associated (Cas) Genes Market: Research and Development Institutes (2015-2020) (K Units)
Figure 26. Global CRISPR And CRISPR-Associated (Cas) Genes Market: Research and Development Institutes (2015-2020) ($ Millions)
Figure 27. Global CRISPR And CRISPR-Associated (Cas) Genes Consumption Market Share by Application (2015-2020)
Figure 28. Global CRISPR And CRISPR-Associated (Cas) Genes Value Market Share by Application (2015-2020)
Figure 29. Global CRISPR And CRISPR-Associated (Cas) Genes Sales Market Share by Company in 2017
Figure 30. Global CRISPR And CRISPR-Associated (Cas) Genes Sales Market Share by Company in 2019
Figure 31. Global CRISPR And CRISPR-Associated (Cas) Genes Revenue Market Share by Company in 2017
Figure 32. Global CRISPR And CRISPR-Associated (Cas) Genes Revenue Market Share by Company in 2019
Figure 33. Global CRISPR And CRISPR-Associated (Cas) Genes Sale Price by Company in 2019
Figure 34. Global CRISPR And CRISPR-Associated (Cas) Genes Consumption Market Share by Regions 2015-2020
Figure 35. Global CRISPR And CRISPR-Associated (Cas) Genes Value Market Share by Regions 2015-2020
Figure 36. Americas CRISPR And CRISPR-Associated (Cas) Genes Consumption 2015-2020 (K Units)
Figure 37. Americas CRISPR And CRISPR-Associated (Cas) Genes Value 2015-2020 ($ Millions)
Figure 38. APAC CRISPR And CRISPR-Associated (Cas) Genes Consumption 2015-2020 (K Units)
Figure 39. APAC CRISPR And CRISPR-Associated (Cas) Genes Value 2015-2020 ($ Millions)
Figure 40. Europe CRISPR And CRISPR-Associated (Cas) Genes Consumption 2015-2020 (K Units)
Figure 41. Europe CRISPR And CRISPR-Associated (Cas) Genes Value 2015-2020 ($ Millions)
Figure 42. Middle East & Africa CRISPR And CRISPR-Associated (Cas) Genes Consumption 2015-2020 (K Units)
Figure 43. Middle East & Africa CRISPR And CRISPR-Associated (Cas) Genes Value 2015-2020 ($ Millions)
Figure 44. Americas CRISPR And CRISPR-Associated (Cas) Genes Consumption Market Share by Countries in 2019
Figure 45. Americas CRISPR And CRISPR-Associated (Cas) Genes Value Market Share by Countries in 2019
Figure 46. Americas CRISPR And CRISPR-Associated (Cas) Genes Consumption Market Share by Type in 2019
Figure 47. Americas CRISPR And CRISPR-Associated (Cas) Genes Consumption Market Share by Application in 2019
Figure 48. United States CRISPR And CRISPR-Associated (Cas) Genes Consumption Growth 2015-2020 (K Units)
Figure 49. United States CRISPR And CRISPR-Associated (Cas) Genes Value Growth 2015-2020 ($ Millions)
Figure 50. Canada CRISPR And CRISPR-Associated (Cas) Genes Consumption Growth 2015-2020 (K Units)
Figure 51. Canada CRISPR And CRISPR-Associated (Cas) Genes Value Growth 2015-2020 ($ Millions)
Figure 52. Mexico CRISPR And CRISPR-Associated (Cas) Genes Consumption Growth 2015-2020 (K Units)
Figure 53. Mexico CRISPR And CRISPR-Associated (Cas) Genes Value Growth 2015-2020 ($ Millions)
Figure 54. APAC CRISPR And CRISPR-Associated (Cas) Genes Consumption Market Share by Countries in 2019
Figure 55. APAC CRISPR And CRISPR-Associated (Cas) Genes Value Market Share by Regions in 2019
Figure 56. APAC CRISPR And CRISPR-Associated (Cas) Genes Consumption Market Share by Type in 2019
Figure 57. APAC CRISPR And CRISPR-Associated (Cas) Genes Consumption Market Share by Application in 2019
Figure 58. China CRISPR And CRISPR-Associated (Cas) Genes Consumption Growth 2015-2020 (K Units)
Figure 59. China CRISPR And CRISPR-Associated (Cas) Genes Value Growth 2015-2020 ($ Millions)
Figure 60. Japan CRISPR And CRISPR-Associated (Cas) Genes Consumption Growth 2015-2020 (K Units)
Figure 61. Japan CRISPR And CRISPR-Associated (Cas) Genes Value Growth 2015-2020 ($ Millions)
Figure 62. Korea CRISPR And CRISPR-Associated (Cas) Genes Consumption Growth 2015-2020 (K Units)
Figure 63. Korea CRISPR And CRISPR-Associated (Cas) Genes Value Growth 2015-2020 ($ Millions)
Figure 64. Southeast Asia CRISPR And CRISPR-Associated (Cas) Genes Consumption Growth 2015-2020 (K Units)
Figure 65. Southeast Asia CRISPR And CRISPR-Associated (Cas) Genes Value Growth 2015-2020 ($ Millions)
Figure 66. India CRISPR And CRISPR-Associated (Cas) Genes Consumption Growth 2015-2020 (K Units)
Figure 67. India CRISPR And CRISPR-Associated (Cas) Genes Value Growth 2015-2020 ($ Millions)
Figure 68. Australia CRISPR And CRISPR-Associated (Cas) Genes Consumption Growth 2015-2020 (K Units)
Figure 69. Australia CRISPR And CRISPR-Associated (Cas) Genes Value Growth 2015-2020 ($ Millions)
Figure 70. Europe CRISPR And CRISPR-Associated (Cas) Genes Consumption Market Share by Countries in 2019
Figure 71. Europe CRISPR And CRISPR-Associated (Cas) Genes Value Market Share by Countries in 2019
Figure 72. Europe CRISPR And CRISPR-Associated (Cas) Genes Consumption Market Share by Type in 2019
Figure 73. Europe CRISPR And CRISPR-Associated (Cas) Genes Consumption Market Share by Application in 2019
Figure 74. Germany CRISPR And CRISPR-Associated (Cas) Genes Consumption Growth 2015-2020 (K Units)
Figure 75. Germany CRISPR And CRISPR-Associated (Cas) Genes Value Growth 2015-2020 ($ Millions)
Figure 76. France CRISPR And CRISPR-Associated (Cas) Genes Consumption Growth 2015-2020 (K Units)
Figure 77. France CRISPR And CRISPR-Associated (Cas) Genes Value Growth 2015-2020 ($ Millions)
Figure 78. UK CRISPR And CRISPR-Associated (Cas) Genes Consumption Growth 2015-2020 (K Units)
Figure 79. UK CRISPR And CRISPR-Associated (Cas) Genes Value Growth 2015-2020 ($ Millions)
Figure 80. Italy CRISPR And CRISPR-Associated (Cas) Genes Consumption Growth 2015-2020 (K Units)
Figure 81. Italy CRISPR And CRISPR-Associated (Cas) Genes Value Growth 2015-2020 ($ Millions)
Figure 82. Russia CRISPR And CRISPR-Associated (Cas) Genes Consumption Growth 2015-2020 (K Units)
Figure 83. Russia CRISPR And CRISPR-Associated (Cas) Genes Value Growth 2015-2020 ($ Millions)
Figure 84. Middle East & Africa CRISPR And CRISPR-Associated (Cas) Genes Consumption Market Share by Countries in 2019
Figure 85. Middle East & Africa CRISPR And CRISPR-Associated (Cas) Genes Value Market Share by Countries in 2019
Figure 86. Middle East & Africa CRISPR And CRISPR-Associated (Cas) Genes Consumption Market Share by Type in 2019
Figure 87. Middle East & Africa CRISPR And CRISPR-Associated (Cas) Genes Consumption Market Share by Application in 2019
Figure 88. Egypt CRISPR And CRISPR-Associated (Cas) Genes Consumption Growth 2015-2020 (K Units)
Figure 89. Egypt CRISPR And CRISPR-Associated (Cas) Genes Value Growth 2015-2020 ($ Millions)
Figure 90. South Africa CRISPR And CRISPR-Associated (Cas) Genes Consumption Growth 2015-2020 (K Units)
Figure 91. South Africa CRISPR And CRISPR-Associated (Cas) Genes Value Growth 2015-2020 ($ Millions)
Figure 92. Israel CRISPR And CRISPR-Associated (Cas) Genes Consumption Growth 2015-2020 (K Units)
Figure 93. Israel CRISPR And CRISPR-Associated (Cas) Genes Value Growth 2015-2020 ($ Millions)
Figure 94. Turkey CRISPR And CRISPR-Associated (Cas) Genes Consumption Growth 2015-2020 (K Units)
Figure 95. Turkey CRISPR And CRISPR-Associated (Cas) Genes Value Growth 2015-2020 ($ Millions)
Figure 96. GCC Countries CRISPR And CRISPR-Associated (Cas) Genes Consumption Growth 2015-2020 (K Units)
Figure 97. GCC Countries CRISPR And CRISPR-Associated (Cas) Genes Value Growth 2015-2020 ($ Millions)
Figure 98. Global CRISPR And CRISPR-Associated (Cas) Genes Consumption Growth Rate Forecast (2021-2025) (K Units)
Figure 99. Global CRISPR And CRISPR-Associated (Cas) Genes Value Growth Rate Forecast (2021-2025) ($ Millions)
Figure 100. Americas CRISPR And CRISPR-Associated (Cas) Genes Consumption 2021-2025 (K Units)
Figure 101. Americas CRISPR And CRISPR-Associated (Cas) Genes Value 2021-2025 ($ Millions)
Figure 102. APAC CRISPR And CRISPR-Associated (Cas) Genes Consumption 2021-2025 (K Units)
Figure 103. APAC CRISPR And CRISPR-Associated (Cas) Genes Value 2021-2025 ($ Millions)
Figure 104. Europe CRISPR And CRISPR-Associated (Cas) Genes Consumption 2021-2025 (K Units)
Figure 105. Europe CRISPR And CRISPR-Associated (Cas) Genes Value 2021-2025 ($ Millions)
Figure 106. Middle East & Africa CRISPR And CRISPR-Associated (Cas) Genes Consumption 2021-2025 (K Units)
Figure 107. Middle East & Africa CRISPR And CRISPR-Associated (Cas) Genes Value 2021-2025 ($ Millions)
Figure 108. United States CRISPR And CRISPR-Associated (Cas) Genes Consumption 2021-2025 (K Units)
Figure 109. United States CRISPR And CRISPR-Associated (Cas) Genes Value 2021-2025 ($ Millions)
Figure 110. Canada CRISPR And CRISPR-Associated (Cas) Genes Consumption 2021-2025 (K Units)
Figure 111. Canada CRISPR And CRISPR-Associated (Cas) Genes Value 2021-2025 ($ Millions)
Figure 112. Mexico CRISPR And CRISPR-Associated (Cas) Genes Consumption 2021-2025 (K Units)
Figure 113. Mexico CRISPR And CRISPR-Associated (Cas) Genes Value 2021-2025 ($ Millions)
Figure 114. Brazil CRISPR And CRISPR-Associated (Cas) Genes Consumption 2021-2025 (K Units)
Figure 115. Brazil CRISPR And CRISPR-Associated (Cas) Genes Value 2021-2025 ($ Millions)
Figure 116. China CRISPR And CRISPR-Associated (Cas) Genes Consumption 2021-2025 (K Units)
Figure 117. China CRISPR And CRISPR-Associated (Cas) Genes Value 2021-2025 ($ Millions)
Figure 118. Japan CRISPR And CRISPR-Associated (Cas) Genes Consumption 2021-2025 (K Units)
Figure 119. Japan CRISPR And CRISPR-Associated (Cas) Genes Value 2021-2025 ($ Millions)
Figure 120. Korea CRISPR And CRISPR-Associated (Cas) Genes Consumption 2021-2025 (K Units)
Figure 121. Korea CRISPR And CRISPR-Associated (Cas) Genes Value 2021-2025 ($ Millions)
Figure 122. Southeast Asia CRISPR And CRISPR-Associated (Cas) Genes Consumption 2021-2025 (K Units)
Figure 123. Southeast Asia CRISPR And CRISPR-Associated (Cas) Genes Value 2021-2025 ($ Millions)
Figure 124. India CRISPR And CRISPR-Associated (Cas) Genes Consumption 2021-2025 (K Units)
Figure 125. India CRISPR And CRISPR-Associated (Cas) Genes Value 2021-2025 ($ Millions)
Figure 126. Australia CRISPR And CRISPR-Associated (Cas) Genes Consumption 2021-2025 (K Units)
Figure 127. Australia CRISPR And CRISPR-Associated (Cas) Genes Value 2021-2025 ($ Millions)
Figure 128. Germany CRISPR And CRISPR-Associated (Cas) Genes Consumption 2021-2025 (K Units)
Figure 129. Germany CRISPR And CRISPR-Associated (Cas) Genes Value 2021-2025 ($ Millions)
Figure 130. France CRISPR And CRISPR-Associated (Cas) Genes Consumption 2021-2025 (K Units)
Figure 131. France CRISPR And CRISPR-Associated (Cas) Genes Value 2021-2025 ($ Millions)
Figure 132. UK CRISPR And CRISPR-Associated (Cas) Genes Consumption 2021-2025 (K Units)
Figure 133. UK CRISPR And CRISPR-Associated (Cas) Genes Value 2021-2025 ($ Millions)
Figure 134. Italy CRISPR And CRISPR-Associated (Cas) Genes Consumption 2021-2025 (K Units)
Figure 135. Italy CRISPR And CRISPR-Associated (Cas) Genes Value 2021-2025 ($ Millions)
Figure 136. Russia CRISPR And CRISPR-Associated (Cas) Genes Consumption 2021-2025 (K Units)
Figure 137. Russia CRISPR And CRISPR-Associated (Cas) Genes Value 2021-2025 ($ Millions)
Figure 138. Spain CRISPR And CRISPR-Associated (Cas) Genes Consumption 2021-2025 (K Units)
Figure 139. Spain CRISPR And CRISPR-Associated (Cas) Genes Value 2021-2025 ($ Millions)
Figure 140. Egypt CRISPR And CRISPR-Associated (Cas) Genes Consumption 2021-2025 (K Units)
Figure 141. Egypt CRISPR And CRISPR-Associated (Cas) Genes Value 2021-2025 ($ Millions)
Figure 142. South Africa CRISPR And CRISPR-Associated (Cas) Genes Consumption 2021-2025 (K Units)
Figure 143. South Africa CRISPR And CRISPR-Associated (Cas) Genes Value 2021-2025 ($ Millions)
Figure 144. Israel CRISPR And CRISPR-Associated (Cas) Genes Consumption 2021-2025 (K Units)
Figure 145. Israel CRISPR And CRISPR-Associated (Cas) Genes Value 2021-2025 ($ Millions)
Figure 146. Turkey CRISPR And CRISPR-Associated (Cas) Genes Consumption 2021-2025 (K Units)
Figure 147. Turkey CRISPR And CRISPR-Associated (Cas) Genes Value 2021-2025 ($ Millions)
Figure 148. GCC Countries CRISPR And CRISPR-Associated (Cas) Genes Consumption 2021-2025 (K Units)
Figure 149. GCC Countries CRISPR And CRISPR-Associated (Cas) Genes Value 2021-2025 ($ Millions)
Figure 150. Caribou Biosciences CRISPR And CRISPR-Associated (Cas) Genes Market Share (2018-2020)
Figure 151. Intellia Therapeutics CRISPR And CRISPR-Associated (Cas) Genes Market Share (2018-2020)
Figure 152. Addgene CRISPR And CRISPR-Associated (Cas) Genes Market Share (2018-2020)
Figure 153. Merck KGaA CRISPR And CRISPR-Associated (Cas) Genes Market Share (2018-2020)
Figure 154. Mirus Bio LLC CRISPR And CRISPR-Associated (Cas) Genes Market Share (2018-2020)
Figure 155. CRISPR THERAPEUTICS CRISPR And CRISPR-Associated (Cas) Genes Market Share (2018-2020)
Figure 156. Thermo Fisher Scientific CRISPR And CRISPR-Associated (Cas) Genes Market Share (2018-2020)
Figure 157. Editas Medicine CRISPR And CRISPR-Associated (Cas) Genes Market Share (2018-2020)
Figure 158. Horizon Discovery Group CRISPR And CRISPR-Associated (Cas) Genes Market Share (2018-2020)
Figure 159. Takara Bio USA CRISPR And CRISPR-Associated (Cas) Genes Market Share (2018-2020)
Figure 160. GE Healthcare Dharmacon CRISPR And CRISPR-Associated (Cas) Genes Market Share (2018-2020)
Reason to Buy
- Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Pharma & Healthcare Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets